occurring in the province of Ontario from 2005 to 2014. Surgeon annual volume was classified by quintiles, with the highest annual volume acting as the reference category for the analysis. Multivariable logistic regression modeling was used, adjusting for patient factors (age, sex, comorbidities, year of procedure, income), surgeon years of experience and clustering amongst institutions, to investigate the relationship between surgeon annual volume and 30-day mortality, 30-day complications (myocardial infarction, stroke, hemorrhage, infection, pneumonia, deep vein thrombosis/pulmonary embolism, acute renal failure), 30-day reoperations (related to index procedure), 1-year mortality, and 1-year reoperations. The potential effects of annual surgeon composite volume and surgeon years of experience on postoperative outcomes were also explored.
occurring in the province of Ontario from 2005 to 2014. Surgeon annual volume was classified by quintiles, with the highest annual volume acting as the reference category for the analysis. Multivariable logistic regression modeling was used, adjusting for patient factors (age, sex, comorbidities, year of procedure, income), surgeon years of experience and clustering amongst institutions, to investigate the relationship between surgeon annual volume and 30-day mortality, 30-day complications (myocardial infarction, stroke, hemorrhage, infection, pneumonia, deep vein thrombosis/pulmonary embolism, acute renal failure), 30-day reoperations (related to index procedure), 1-year mortality, and 1-year reoperations. The potential effects of annual surgeon composite volume and surgeon years of experience on postoperative outcomes were also explored.
Results: A total of 7211 elective open AAA repairs performed by 101 surgeons were included. Most of the operations were performed by vascular surgeons (81.5%), followed by cardiac (12.1%) and general surgeons (6.1%). Median number of procedures in the low quintile group was three repairs per year, while the very high quintile group performed 54 repairs per year. Overall 30-day mortality was 3%, with no effect of surgeon volume when comparing lowest volume to highest volume quintiles (P ¼ .21). The lowest volume group exhibited a higher 30-day complication rate (28.0% vs 20.4%; odds ratio, 1.54; 95% confidence interval, 1.15-2.06) and 30-day reoperation rate (10.53% vs 6.73%; odds ratio, 1.63; 95% confidence interval, 1.18-2.26) when compared to the highest volume group. No effect of surgeon volume on 1-year mortality, or 1-year reoperation was observed. Similarly, composite volume and surgeon years of experience did not significantly impact postoperative mortality.
Conclusions: Higher surgeon annual volume resulted in lower postoperative complication and reoperation rates, while having no effect on postoperative mortality. Surgeon years of experience did not influence outcomes suggesting that annual volume is more important than surgeon seniority in dictating outcomes after elective open AAA repair.
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PC012.
Contemporary Mortality Rates After Endovascular Aortic Repair in Patients Unfit for Open Aortic Surgery: Is It Time to Revisit Endovascular Aortic Repair-2 Trial?
Megan C. Turner, Shaunak Adkar, Harold J. Leraas, Uttara Nag, Brian F. Gilmore, Ryan S. Turley, Cynthia Shortell, Leila Mureebe. Duke University Medical Center, Durham, NC Objectives: The 2010 Endovascular Aortic Repair-2 Trial (EVAR-2) reported that patients with comorbidity profiles rendering them unfit for open aneurysm repair who underwent endovascular aortic repair (EVAR) did not result in a survival advantage compared those who did not undergo intervention. These patients experienced a 30-day mortality of 7.3%, while reports from similar cohorts report far lower mortality rates. The primary objective of our study was to compare the incidence of 30-day mortality in low-and high-risk patients undergoing EVAR in a contemporary dataset, using patient risk stratification criteria from EVAR-2. Secondarily, we sought to identify risk factors associated with a disproportionate contribution to 30-day mortality risk.
Methods: Data was obtained from the 2005 to 2013 American College of Surgeons National Surgical Quality Improvement Program participant user files (n ¼ 24,813). Patients were included in the high-risk cohort with the presence of renal, respiratory, or cardiac preoperative criteria alone or in combination. Renal criteria were defined as dialysis, or creatinine >2.26 mg/dL. Respiratory criteria included history of chronic obstructive pulmonary disease, or preoperative ventilator support. Cardiac criteria included history of myocardial infarction, congestive heart failure, angina, or prior coronary intervention. Patient, procedural characteristics and 30-day postoperative outcomes were compared using Pearson c 2 tests for categoric variables and Wilcoxon rank sum tests for continuous variables.
Results: Among 24,813 patients undergoing EVAR, 12,031 patients (48%) were characterized as high-risk while 12,770 patients (52%) were stratified as low-risk. Thirty-day mortality rate in the high-risk cohort was 1.9%, compared to the 7.3% reported by EVAR-2, and higher in the high-risk cohort compared to the low-risk cohort (1.9% vs 0.9%; P < .001). While the presence of each comorbidity increased the odds of 30-day mortality (respiratory: odds ratio [OR], 1.62; 95% confidence interval [CI], 1.16-2.26; P ¼ .005; cardiac: OR, 1.55; 95% CI, 1.14-2.10; P ¼ .005), the presence of renal criteria disproportionately increased the odds of mortality threefold (OR, 3.42; 95% CI: 2.31-5.09; P < .001). Thirty-day mortality rates compounded with increasing numbers of comorbidities: patients with one comorbidity criterion experienced a 1.6% 30-day mortality, up to 8.7% in patients meeting three criteria (P < .001).
Conclusions: Contemporary 30-day mortality following EVAR in highrisk patients is substantially lower than that reported in the EVAR-2 trial. While low-and high-risk stratification by current comorbidity criteria is appropriate, attention needs to be paid to disproportionate risk contribution from renal disease on mortality compared to cardiac and pulmonary comorbidities. Given the lower mortality risk than previously described, patients stratified as high-risk should be thoughtfully considered for definitive endovascular aneurysm repair.
Author Disclosures: S. Adkar: Nothing to disclose; B. F. Gilmore: Nothing to disclose; H. J. Leraas: Nothing to disclose; L. Mureebe: Nothing to disclose; U. Nag: Nothing to disclose; C. Shortell: Nothing to disclose; R. S. Turley: Nothing to disclose; M. C. Turner: Nothing to disclose. Objectives: Fenestrated/branched endovascular repair (F/BEVAR) is a complex procedure that can be complicated, prolonged, and/or aborted due to difficult access vessel issues. Specifically, patients with significant aortoiliac occlusive disease, pre-existing endografts, and/or unilateral iliac occlusion represent a unique cohort with limited data regarding outcomes after F/BEVAR. This study describes our experience with challenging iliac anatomy in F/BEVAR patients.
PC014.

Challenging Iliac Anatomy in Fenestrated Endovascular Aortic Aneurysm Repair
Methods: A retrospective analysis of a prospectively maintained F/BEVAR database was performed on all procedures from 2009 to 2016. Operative details, including access vessel delivery approach, adjunct procedures, open/endovascular conduit use, and device configuration was abstracted. Challenging iliac anatomy was defined by use of open/ endoconduit, preemptive iliac angioplasty, aortouniiliac devices, and/or 30-day mortality 2 (3.6) 9 (3.4) .97
Postoperative complication 11 (19) 38 (14) .34
a Data are presented as number (%) or mean 6 standard deviation.
